Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sai Primus Lifebiotech is an Indian pharmaceutical and nutraceutical Contract Development and Manufacturing Organization (CDMO) specializing in oral solid dosage (OSD) formulations, including tablets and capsules. Founded in 2017 and headquartered in Puducherry, India, the company provides third-party contract manufacturing, private labeling, product development, regulatory support, and direct branding under its own 'SPL' brand. Its diversified portfolio spans over 279 pharmaceutical and 170 nutraceutical products across therapeutic segments such as anti-diabetics, anti-hypertensives, anti-infectives, and analgesics. The company operates a WHO-GMP certified manufacturing facility supported by in-house R&D, Quality Assurance, and Quality Control laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sai Primus Life Biotech.